Mojave Therapeutics, Inc.
22 Saw Mill River Road
Hawthorne
New York
10532-1533
U.S.A.
Phone:
914-347-0290
Fax:
914-347-0292
|
Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave's core technologies, developed by leading researchers at Memorial Sloan-Kettering Cancer Center, use highly targeted and modular antigen delivery systems that allow the rapid development of a broad range of immunotherapeutic products.
Mojave's goal is to develop off-the-shelf products that will provide significant advances in the treatment of cancer and viral diseases for which current therapies are ineffective or have undesirable side effects. The Company's core technologies are based on the use of specific human proteins called heat shock proteins as antigen delivery systems that generate powerful immune responses. Mojave has developed the proprietary Javelin™ and DART™ technology platforms for antigen delivery.
For more information about Mojave, please visit us at www.mojave-therapeutics.com.
Last Updated: 08-07-02
Email:
mojave@mojave-therapeutics.com
Ownership:
Private
Web Site:
Mojave Therapeutics, Inc.
Employees:
Symbol:
|